IGTP is appointed as ‘EATRIS Expert Centre’

EATRIS, the European infrastructure for translational medicine, has appointed 7 Expert Centres, to provide high value added services historically offered by EATRIS Coordination and Support. Those expert services that are complementary to the existing laboratory research services offered by EATRIS institutions cover crucial areas such as innovation management, regulatory strategy, translational feasibility, and early health technology assessment. With 7 newly appointed Expert Centres, EATRIS will continue serving Europe's translational research efforts and growing demand for expert services.

Four IGTP spin-offs selected in the WomenTechEU call

The European Commission has announced the results of the second WomenTechEU call, which aims to support innovative European deep-tech companies founded by women. This year, 134 women-led companies have been chosen to receive a €75,000 grant to assist with their innovation process and company growth. Among the selected companies are four spin-offs from the Germans Trias i Pujol Research Institute (IGTP). These companies represent a portion of the 20 Catalan women-led companies selected in the WomenTechEU call.

Aniling, IGTP and ICO awarded €1.8 million from the Spanish government to develop a theragnostic tool for personalised management of colorectal cancer

The consortium made up of Aniling, the Germans Trias i Pujol Research Institute (IGTP) and the Institut Català d’Oncologia (ICO) has been awarded €1.8 million from the Spanish State Research Agency (AEI) for the development of a new theragnostic tool to personalise the management of colorectal cancer (CRC) patients.

IGTP receives the visit of Cristóbal Belda, director of the Instituto de Salud Carlos III

The visit of the director of the Instituto de Salud Carlos III (ISCIII) -a public body attached to the Ministry of Science and Innovation, responsible for the promotion, coordination and funding of health research- at the Germans Trias i Pujol Research Institute (IGTP) was an opportunity to gain direct insight into the latest advances and research while addressing strategic issues.

State funding of €1.8M to develop an advanced gene therapy for Friedreich's ataxia

The Centre for the Development of Industrial Technology (CDTI) and the Carlos III Health Institute (ISCII) will fund the project with 1.8 million euros within the R&D&I call linked to Personalised Medicine and Advanced Therapies in the framework of the Strategic Project for the Recovery and Economic Transformation for Vanguard Health (PERTE for Vanguard Health) in gene therapy for Friedreich's ataxia.

Nimble Diagnostics closes a financing round of one million euros

NIMBLE Diagnostics, a spin-off from the Germans Trias i Pujol Research Institute (IGTP), the Polytechnic University of Catalonia – BarcelonaTech (UPC) and the University of Barcelona (UB), has successfully closed a funding round led by Grow Ventures together with Namarel Ventures and Inveniam Group where they have secured more than one million euros. NIMBLE is developing the first medical device to monitor patients with implanted stents, thus avoiding serious complications and improving the clinical management of millions of patients each year.

European Commission’s drive to launch a medical device created in the Hospital and the Germans Trias i Pujol Research Institute to improve the diagnosis and prognosis of the acute ischaemic stroke

The care and treatment provided to people who suffer an ischemic stroke can improve thanks to a technology developed in Catalonia. This is the purpose of Time is Brain (TiB), a start-up that arose from a scientific project carried out by the Hospital and the Germans Trias i Pujol Research Institute (IGTP), which has just received an investment by the European Union of almost 6 million euros in order for the hospitals to count on a pioneering device to manage acute ischaemic stroke.

Two IGTP projects, financed with 1.6 million euros by the European Commission

The European Commission has granted two projects to the IGTP within the HORIZON programme, which add up to a total of 1,670,346 euros in funding and deal with the preclinical development of immunotherapies.

Reformulating clinical internships: an innovative teaching approach at IGTP

The Germans Trias i Pujol Research Institute (IGTP) and the Germans Trias Hospital participate in the HEAL project, which is funded through the Erasmus+ programme. HEAL is an ambitious project aimed at reformulating the way clinical internships currently take place in hospitals.

Breaz Medical, a new spin-off of IGTP for the timely diagnosis of COPD

• Timely diagnosis is crucial to detect chronic obstructive pulmonary disease (COPD), an underdiagnosed entity in 75% of cases
• Breaz is developing a fast and precise testing device to improve the diagnosis and prognosis of this respiratory disease